Skip to content
MedsAcross

Medicine

Ethosuximide 250 mg capsule

Ethosuximide · Oral
Available on requestPrescription onlyUS FDAGeneric name

Ethosuximide 250 mg capsule is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25° C (68° to 77° F).

Key facts

Active ingredient (INN)
Ethosuximide
Brand
Sold under the generic name
Strength
250 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 120 capsules, 90 capsules and 3 more
Manufacturers
Strides PharmaIndiaEpic PharmaBionpharmaBryant Ranch PrepackChartwell RX
Origin register
US FDA, United States
Storage
Store at 20° to 25° C (68° to 77° F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AD01 Ethosuximide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 September 2015
Identifiers
RxCUI 197682DailyMed set ID 85c50760-98cc-4888-b27f-146937acc893, a040dab2-0d70-4c02-a830-5ba1e3506a1b, efb047e8-0020-4504-97fa-6aa1af3af05e +3NDC 42806-708, 42806-711, 69452-152 +3Application ANDA210654, ANDA040430, ANDA200892 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle64380-878-06Strides PharmaIndia15 May 2019
100 capsule in 1 bottle42806-708-01Epic Pharma12 November 2021
100 capsule in 1 bottle42806-711-01Epic Pharma15 April 2020
100 capsule, liquid filled in 1 bottle, plastic69452-152-20Bionpharma21 October 2016
120 capsule in 1 bottle62135-790-12Chartwell RX23 October 2023
90 capsule, liquid filled in 1 bottle63629-8005-1Bryant Ranch Prepack9 May 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 2 November 1960Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ethosuximide 250 mg capsule.

Compare 1

Other strengths and forms of Ethosuximide

Clinical summary

Ethosuximide is an anti-epileptic agent indicated for the control of absence (petit mal) epilepsy. It is available as capsules and oral solution. MedsAcross supplies Ethosuximide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ethosuximide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ethosuximide 250 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.